Peijia Medical Limited (4WO) - Total Liabilities
Based on the latest financial reports, Peijia Medical Limited (4WO) has total liabilities worth €798.71 Million EUR (≈ $933.77 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Peijia Medical Limited - Total Liabilities Trend (2018–2025)
This chart illustrates how Peijia Medical Limited's total liabilities have evolved over time, based on quarterly financial data. See 4WO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Peijia Medical Limited Competitors by Total Liabilities
The table below lists competitors of Peijia Medical Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Materialise NV
NASDAQ:MTLS
|
USA | $162.93 Million |
|
Shandong Sito Bio-technology Co Ltd
SHE:300583
|
China | CN¥1.06 Billion |
|
Jiangsu Xinning Modern Logist
SHE:300013
|
China | CN¥354.76 Million |
|
Silence Therapeutics PLC
NASDAQ:SLN
|
USA | $72.73 Million |
|
Citizens Financial Services Inc. Common Stock
NASDAQ:CZFS
|
USA | $2.68 Billion |
|
Tehmag Foods
TWO:1264
|
Taiwan | NT$1.43 Billion |
|
STP&I Public Company Limited
BK:STPI
|
Thailand | ฿5.97 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Peijia Medical Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4WO stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Peijia Medical Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Peijia Medical Limited (2018–2025)
The table below shows the annual total liabilities of Peijia Medical Limited from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €798.71 Million ≈ $933.77 Million |
+24.00% |
| 2024-12-31 | €644.11 Million ≈ $753.03 Million |
+61.88% |
| 2023-12-31 | €397.88 Million ≈ $465.17 Million |
-41.39% |
| 2022-12-31 | €678.86 Million ≈ $793.66 Million |
+369.85% |
| 2021-12-31 | €144.48 Million ≈ $168.92 Million |
+112.49% |
| 2020-12-31 | €67.99 Million ≈ $79.49 Million |
-95.27% |
| 2019-12-31 | €1.44 Billion ≈ $1.68 Billion |
+435.05% |
| 2018-12-31 | €268.70 Million ≈ $314.14 Million |
-- |
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more